Pharmacokinetics of CVL-231 Following Single Oral Administration of Modified- and Immediate-release Formulations in Fasted and Fed Healthy Participants
Clinical trial NCT05106309 · COMPLETED
Trial details
- NCT number
- NCT05106309
- Sponsor
- Cerevel Therapeutics, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-29
- Primary completion
- 2022-02-24
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.